GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 26601 - 26650 of 39437 in total
PDB ID ▲ UniProt ID Title Descriptor
7L57 P0DTC2 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain
7L57 7L57 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain
7L58 P0DTC2 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain
7L58 7L58 Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 Spike glycoprotein, Fab H4 variable domain heavy chain, Fab H4 variable domain light chain
7L5K A0A768MZ64 Crystal structure of the DiB-RM protein
7L61 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose
7L62 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose
7L63 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose
7L64 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a
7L65 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc
7L66 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc
7L67 P22897 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Fuc-(alpha1-3)-GlcNAc
7L6O A0A1W6IPB2 Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41
7L6O 7L6O Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp120, CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 - gp41
7L6R P0DTD1 Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and Manganese (Mn).
7L6T P0DTD1 Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and two Magnesium (Mg) ions.
7L74 Q564N5 Crystal structure of Beta-hexosyl transferase from Hamamotoa (Sporobolomyces) singularis bound to TRIS
7L7D P0DTC2 Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895
7L7D 7L7D Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895
7L7E 7L7E Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
7L7E P0DTC2 Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
7L7R 7L7R CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs
7L7R Q8JSZ3 CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs
7L7T 7L7T BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A)
7L7U 7L7U BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B)
7L86 7L86 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point)
7L87 7L87 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point)
7L88 7L88 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point)
7L89 7L89 BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point)
7L8A 7L8A BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point)
7L8B 7L8B BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point)
7L8C 7L8C BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point)
7L8D 7L8D BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point)
7L8E Q2N0S5 BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point)
7L8E 7L8E BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time point)
7L8F Q2N0S5 BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point)
7L8F 7L8F BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point)
7L8G Q2N0S5 BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point)
7L8G 7L8G BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time point)
7L8P P08514 Integrin alphaIIbbeta3 in complex with sibrafiban
7L8P P05106 Integrin alphaIIbbeta3 in complex with sibrafiban
7L8P 7L8P Integrin alphaIIbbeta3 in complex with sibrafiban
7L8S 7L8S BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time point)
7L8T 7L8T BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 time point)
7L8U 7L8U BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 time point)
7L8W 7L8W BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 time point)
7L8X 7L8X BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 time point)
7L8Y 7L8Y BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 time point)
7L8Z 7L8Z BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 time point)
7L90 7L90 BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 time point)

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024